Dec 31, 2021 05:30 PM (GMT+8) · EqualOcean
Today, according to the website of Shanghai Stock Exchange, the application of Shanghai Lianying Medical Technology Co., Ltd. for listing on the science and innovation board has been accepted. The main business of Lianying medical is high-performance medical imaging equipment, radiotherapy products and life science instruments, and provides medical digitization and intelligent solutions. According to the prospectus, in 2020, the company achieved a revenue of 5.7 billion yuan, a year-on-year increase of 94.11%. From January to June 2021, the company achieved a revenue of about 3.1 billion yuan. During the reporting period, the company has obtained more than 1500 authorized invention patents, including more than 1100 domestic invention patents and more than 380 overseas invention patents.